The ORIGINAL Biomarker Meeting

Cambridge Healthtech Institute’s Seventeenth Annual Biomarkers & Precision Oncology World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. Since 2004, the Congress has emerged as the leading annual meeting where big pharma and biotech drive innovation and collaboration in clinical and translational biomarkers, precision medicine and companion diagnostics, precision oncology and immuno-oncology biomarkers, liquid biopsy, spatial biology and single-cell analysis. Please join us for comprehensive scientific coverage and unparalleled networking opportunities at the in-person Biomarkers & Precision Oncology World Congress 2022 in Boston!